0
0

Of inquiry directing the Secretary of Health and Human Services to provide certain documentation to the House of Representatives relating to the negotiation of prices for prescription drugs under the Medicare prescription drug program.

4/17/2024, 11:45 PM

Summary of Bill HRES 1284

Bill 117 H.Res. 1284, also known as the "Of Inquiry Directing the Secretary of Health and Human Services to Provide Certain Documentation to the House of Representatives Relating to the Negotiation of Prices for Prescription Drugs under the Medicare Prescription Drug Program," is a piece of legislation that aims to gather information from the Secretary of Health and Human Services regarding the negotiation of prices for prescription drugs under the Medicare prescription drug program.

The bill directs the Secretary of Health and Human Services to provide specific documentation to the House of Representatives related to the negotiation of prices for prescription drugs under the Medicare prescription drug program. This documentation is intended to shed light on the process by which prices for prescription drugs are determined and negotiated within the program.

The purpose of this bill is to increase transparency and accountability in the negotiation of prescription drug prices under Medicare, with the goal of potentially lowering costs for beneficiaries and improving access to necessary medications. By requiring the Secretary of Health and Human Services to provide this documentation to the House of Representatives, lawmakers can better understand the factors influencing drug pricing and potentially take action to address any issues that may be driving up costs for Medicare beneficiaries. Overall, Bill 117 H.Res. 1284 seeks to gather important information that can inform future policy decisions related to prescription drug pricing under the Medicare program, with the ultimate goal of improving affordability and access to necessary medications for Medicare beneficiaries.

Congressional Summary of HRES 1284

This resolution directs the Department of Health and Human Services (HHS) to furnish to the House of Representatives any external or internal communications of the White House regarding the implications of imposing certain penalties on drug manufacturers that do not comply with HHS price negotiations under the Medicare prescription drug benefit.

Current Status of Bill HRES 1284

Bill HRES 1284 is currently in the status of Bill Introduced since July 26, 2022. Bill HRES 1284 was introduced during Congress 117 and was introduced to the House on July 26, 2022.  Bill HRES 1284's most recent activity was Placed on the House Calendar, Calendar No. 140. as of September 30, 2022

Bipartisan Support of Bill HRES 1284

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HRES 1284

Primary Policy Focus

Health

Potential Impact Areas

- Congressional oversight
- Government information and archives
- Medicare
- Prescription drugs

Comments